Donald E. Tsai

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 454 citations · Full text

Medicine, Oncology, Pharmacology +12

REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1

Donald E. Tsai, Christine Hardy, John E. Tomaszewski et al. · Transplantation · 2001 · 364 citations

Medicine, Immunology, Surgery +16

Treatment of PTLD with Rituximab or Chemotherapy

Rebecca Elstrom, C. Andreadis, Nicole A. Aqui et al. · American Journal of Transplantation · 2006 · 260 citations · Full text

Medicine, Immunology, Oncology +13

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

David Porter, Bruce L. Levine, Nancy Bunin et al. · Blood · 2005 · 219 citations

Life Sciences, Hematology, Immunology +17

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia

Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown et al. · New England Journal of Medicine · 2023 · 217 citations · Full text

Medicine, Oncology, Pharmacology +15